We are your powerful ally in the fight against cancer
At RGCC, we understand that every cancer journey is unique. Each patient reacts differently to standardized treatments, and each tumor should be assessed in a complex and comprehensive manner. Since 2004, we have specialized in cancer genetics, liquid biopsy testing, and chemosensitivity testing, supporting patients and healthcare providers worldwide. Our mission is simple: to help detect cancer earlier, monitor its progression, and support personalized cancer treatment plans tailored to each individual.
We work closely with healthcare providers from our network to analyze blood samples using advanced diagnostic technologies, delivering insights that can support cancer detection, diagnosis, and treatment decisions. This empowers our healthcare partners to individualize your treatment and support you with data-driven guidance to find the cancer treatment plan that is the most effective for you throughout your personalized cancer journey.
Early cancer detection and screening Our advanced Onco-D-Clare test helps identify potential early signs of cancer, including circulating tumor cells (CTCs) and cancer-related biomarkers in the blood.
Cancer monitoring and disease progression Liquid biopsy testing allows ongoing monitoring of cancer, helping your doctor track how your primary cancer and possible metastasis evolve.
Chemosensitivity testing and integrative treatment approaches We provide insights into how your cancer may respond to different chemotherapy drugs and natural supplements, supporting truly individualized and integrative cancer care.
Using a simple blood draw, our tests (sometimes referred to as Greek/Greece Tests) are non-invasive and patient-friendly, minimizing discomfort while providing powerful clinical insights. We specialize in testing circulating tumor cells (CTCs). A CTC test allows real time monitoring of your tumor and can help detect tumor spread and the risk of recurrence early. With the RGCC cancer blood tests we can not only evaluate data from the primary tumor but also from possible metastasis.
Through precision oncology and molecular diagnostics, we analyze tumor-specific and genetic characteristics to help clinicians move beyond a one-size-fits-all approach that may not always work for your cancer.
This means:
More precise treatment strategies
Improved patient safety
Better-informed clinical decisions
Accurate testing backed by advanced laboratories in Europe
All RGCC tests are performed in internationally-accredited laboratories (such as GMP) using cutting-edge technologies. View our accreditations here
Hear from patients using RGCC:
P.W., Europe
“RGCC has been a beacon of reliability and compassion in my cancer journey. Their cutting-edge tests not only provided me with a clear understanding of my diagnosis but also guided my treatment decisions every step of the way.”
L.K., Europe
"I can't thank RGCC Laboratory enough for their incredible diagnostic options throughout my cancer journey. Their tests provided me with the accurate diagnosis I needed to start my treatment plan. Knowing that my care team had access to such reliable information gave me the confidence to face each day with hope."
Getting started is simple, and we’re here to guide you every step of the way:
Contact us, and we’ll help you find a healthcare provider near you
Meet with your clinician to discuss your needs
Provide a simple blood sample during your appointment
Your sample is safely sent to our specialized laboratory in Europe
Our scientists carry out advanced testing and analysis
Your results are shared with your healthcare provider
You and your doctor create a personalized treatment plan
RGCC operates worldwide, giving you access to advanced cancer diagnostics and experienced healthcare providers wherever you are. Contact us to get connected.
